Results 21 to 30 of about 50,334 (225)
Pakistan Armed Forces Medical Journal, 2023 Objectives: To determine the occurrence and severity of thyroid eye disease regarding thyroid function in patients with autoimmune thyroid disease (AITD). Study Design: Cross-sectional study.
Bharta Rani +5 more
doaj +1 more source
Hypo vs. hyperthyroid eye disease: is there any difference?
BMC Ophthalmology, 2023 Background Thyroid-eye disease (TED) is the most common extra-thyroidal presentation of graves’ disease. We performed this study to compare clinical characteristics of TED in hypothyroid vs. hyperthyroid patients.
Bahram Eshraghi +3 more
doaj +1 more source
A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease
American Journal of Ophthalmology Case Reports, 2021 Purpose: To present a case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease. Observations: A 46-year-old Indian female was treated with teprotumumab (Tepezza) for severe thyroid eye disease within 9 months of diagnosis.
Myra B. Safo, Rona Z. Silkiss
doaj +1 more source
Effects of teprotumumab on patients with long-standing, active thyroid eye disease
American Journal of Ophthalmology Case Reports, 2022 Purpose: Describe five cases of long-standing, active thyroid eye disease that responded to treatment with teprotumumab. Observations: Five patients with a greater than 9-month-history of thyroid eye disease, including two patients who had previously ...
Kyle B. Vinson, MD, Maria Kirzhner, MD
doaj +1 more source
Unilateral proptosis in a patient with thyroid eye disease: A case report
SAGE Open Medical Case Reports, 2023 Unilateral proptosis is an abnormality in which one eye sticks out forward more than the other. Bulging of the eye is commonly seen in Graves’ ophthalmopathy, but it’s mostly bilateral.
Himal Bikram Bhattarai +9 more
doaj +1 more source
Folia Medica IndonesianaHighlights: 1. This study, conducted at a tertiary hospital, was the first to analyze the correlation between thyroid status and clinical activity score in thyroid eye disease. 2.
Hasna Shahida Amatlulloh +4 more
doaj +1 more source
Tocilizumab for thyroid eye disease [PDF]
Cochrane Database of Systematic Reviews, 2018 Thyroid eye disease (TED) is an autoimmune disorder that constitutes a major clinical and therapeutic challenge. Current treatment options for moderate-to-severe TED include immunotherapy, orbital radiotherapy and decompression surgery. Limited drugs of proven efficacy are available for the treatment of people with TED.
Shirin, Hamed Azzam +3 more
openaire +3 more sources
Thyroid eye disease: Etiopathogenesis and management
TNOA Journal of Ophthalmic Science and Research, 2022 Thyroid eye disease has been a well-recognized clinical entity related to thyroid gland dysfunction for more than a century. However, the last couple of decades devoted to specific clinical research regarding this entity has significantly contributed to ...
G Seethapathy, V G Madanagopalan
doaj +1 more source
How patients experience thyroid eye disease
Frontiers in Endocrinology, 2023 ObjectiveTo determine the impact of thyroid eye disease (TED) on patients in various stages of the disease.BackgroundTED is a debilitating and potentially sight-threatening inflammatory autoimmune disease that is frequently misdiagnosed.
Terry J. Smith +8 more
doaj +1 more source
Jod-Basedow phenomenon: Reactivation of thyroid eye disease after contrast computed tomography
African Vision and Eye Health, 2018 To report a case of Jod-Basedow phenomenon, where a patient with quiescent thyroid eye disease became active after a contrast computed tomography (CT).
Roland Hollhumer, Francesca Indiveri
doaj +1 more source